The Medicine for This Terminal Disease

Lupu's disease, for some 15,000 people in the United Kingdom, is a daily reality. For decades, medication to this disease and its effects were minor.
But late last year, researchers discovered what they believe is the greatest progress in treating lupus over decades.

The medicine, called Anifroboomab, is able to ease symptoms such as facial frying, swollen, and painful knots, meaning that patients can stop using other pills.

Lupus develops when the body's immune system changes and attacks healthy cells and tissues. This is often the result of a viral infection that patients did not even know they had. As a result, the flow of blood is flooded with interferones, a type of protein that normally patrols the body seeking invading viruses to attack.

The disease gets its Latin name “wuk” because the facial lesions it causes are compared to a wolf bite. In rare cases, rashes can be so heavy, leading to deep wounds and buried on the cheek.

The situation also makes patients so sensitive to the sun's rays that even minutes outside on a hot day can cause the skin to be filled with bubbles, joints to become flammable, and internal organs to swell.